Stead RB - Search Results

1

A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia.

Macdougall IC, Rossert J, Casadevall N, Stead RB, Duliege AM, Froissart M, Eckardt KU. Macdougall IC, et al. Among authors: stead rb. N Engl J Med. 2009 Nov 5;361(19):1848-55. doi: 10.1056/NEJMoa074037. N Engl J Med. 2009. PMID: 19890127 Free article. Clinical Trial.

2

Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model.

Woodburn KW, Fan Q, Winslow S, Chen MJ, Mortensen RB, Casadevall N, Stead RB, Schatz PJ. Woodburn KW, et al. Among authors: stead rb. Exp Hematol. 2007 Aug;35(8):1201-8. doi: 10.1016/j.exphem.2007.05.007. Exp Hematol. 2007. PMID: 17662888 Free article.

3

Population pharmacokinetics and pharmacodynamics of peptidic erythropoiesis receptor agonist (ERA) in healthy volunteers.

Woo S, Krzyzanski W, Duliege AM, Stead RB, Jusko WJ. Woo S, et al. Among authors: stead rb. J Clin Pharmacol. 2008 Jan;48(1):43-52. doi: 10.1177/0091270007309702. Epub 2007 Nov 19. J Clin Pharmacol. 2008. PMID: 18025524

4

Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.

Stead RB, Lambert J, Wessels D, Iwashita JS, Leuther KK, Woodburn KW, Schatz PJ, Okamoto DM, Naso R, Duliege AM. Stead RB, et al. Blood. 2006 Sep 15;108(6):1830-4. doi: 10.1182/blood-2006-04-015818. Epub 2006 May 23. Blood. 2006. PMID: 16720830 Free article. Clinical Trial.

5

Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor.

Harker LA, Marzec UM, Novembre F, Sundell IB, Waller EK, Karpatkin S, McClure HM, Kelly AB, Stead RB. Harker LA, et al. Among authors: stead rb. Blood. 1998 Jun 15;91(12):4427-33. Blood. 1998. PMID: 9616135 Free article.

6

Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates.

Harker LA, Marzec UM, Hunt P, Kelly AB, Tomer A, Cheung E, Hanson SR, Stead RB. Harker LA, et al. Among authors: stead rb. Blood. 1996 Jul 15;88(2):511-21. Blood. 1996. PMID: 8695799 Free article.

7

Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates.

Harker LA, Hunt P, Marzec UM, Kelly AB, Tomer A, Hanson SR, Stead RB. Harker LA, et al. Among authors: stead rb. Blood. 1996 Mar 1;87(5):1833-44. Blood. 1996. PMID: 8634430 Free article.

8

Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.

Harker LA, Marzec UM, Kelly AB, Cheung E, Tomer A, Nichol JL, Hanson SR, Stead RB. Harker LA, et al. Among authors: stead rb. Blood. 1997 Jan 1;89(1):155-65. Blood. 1997. PMID: 8978288 Free article.

9

Preclinical studies and potential clinical applications of c-mpl ligand.

Stead RB, Harker LA. Stead RB, et al. Curr Opin Hematol. 1996 May;3(3):197-202. doi: 10.1097/00062752-199603030-00006. Curr Opin Hematol. 1996. PMID: 9372076 Review.

10

A comparison of therapeutic schedules for administering granulocyte colony-stimulating factor to nonhuman primates after high-dose chemotherapy.

Meisenberg BR, Davis TA, Melaragno AJ, Stead R, Monroy RL. Meisenberg BR, et al. Blood. 1992 May 1;79(9):2267-72. Blood. 1992. PMID: 1373969 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters